| Detailed information |
|---|
| CancerLivER ID | 2238 |
| Biomarker | CCAT1 |
| Biomarker Name/Symbol (given in Publication) | CCAT1 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | CCAT1 for the prognosis and treatment of HCC; but not validated on independent dataset |
| Experimental Condition | HCC v/s Normal; correlated with tumor size, microvascular invasion and poor prognosis |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 25884472 |
| Type of Biomarker | Prognostic |
| Pathway | NA |
| Cohort | 66 pairs of HCC tissues and pair-matched noncancerous hepatic tissues; human HCC cell lines (SMMC-7721, Hep3B, Huh7, and HepG2) and two liver normal cell lines (LO2 and QSG-7701) |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2015 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |